BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23965956)

  • 1. The efficacy of the quorum sensing inhibitor FS8 and tigecycline in preventing prosthesis biofilm in an animal model of staphylococcal infection.
    Simonetti O; Cirioni O; Mocchegiani F; Cacciatore I; Silvestri C; Baldassarre L; Orlando F; Castelli P; Provinciali M; Vivarelli M; Fornasari E; Giacometti A; Offidani A
    Int J Mol Sci; 2013 Aug; 14(8):16321-32. PubMed ID: 23965956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quorum sensing inhibitor FS3-coated vascular graft enhances daptomycin efficacy in a rat model of staphylococcal infection.
    Cirioni O; Mocchegiani F; Cacciatore I; Vecchiet J; Silvestri C; Baldassarre L; Ucciferri C; Orsetti E; Castelli P; Provinciali M; Vivarelli M; Fornasari E; Giacometti A
    Peptides; 2013 Feb; 40():77-81. PubMed ID: 23262356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection.
    Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Silvestri C; Orlando F; Mocchegiani F; Vittoria AD; Kamysz E; Saba V; Scalise G
    Peptides; 2007 Jun; 28(6):1299-303. PubMed ID: 17537542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of the Quorum Sensing Inhibitor FS10 Alone and in Combination with Tigecycline in an Animal Model of Staphylococcal Infected Wound.
    Simonetti O; Cirioni O; Cacciatore I; Baldassarre L; Orlando F; Pierpaoli E; Lucarini G; Orsetti E; Provinciali M; Fornasari E; Di Stefano A; Giacometti A; Offidani A
    PLoS One; 2016; 11(6):e0151956. PubMed ID: 27253706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.
    Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Gov Y; Kamysz W; Lukasiak J; Mocchegiani F; Orlando F; D'Amato G; Balaban N; Saba V; Scalise G
    Circulation; 2003 Aug; 108(6):767-71. PubMed ID: 12885754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron.
    Ghiselli R; Giacometti A; Goffi L; Cirioni O; Mocchegiani F; Orlando F; Paggi AM; Petrelli E; Scalise G; Saba V
    J Surg Res; 2001 Aug; 99(2):316-20. PubMed ID: 11469904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prophylactic efficacy of rifampicin-soaked graft in combination with systemic vancomycin in the prevention of prosthetic vascular graft infection: an experimental study.
    Sacar M; Goksin I; Baltalarli A; Turgut H; Sacar S; Onem G; Ozcan V; Adali F
    J Surg Res; 2005 Dec; 129(2):329-34. PubMed ID: 16360378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daptomycin and rifampin alone and in combination prevent vascular graft biofilm formation and emergence of antibiotic resistance in a subcutaneous rat pouch model of staphylococcal infection.
    Cirioni O; Mocchegiani F; Ghiselli R; Silvestri C; Gabrielli E; Marchionni E; Orlando F; Nicolini D; Risaliti A; Giacometti A
    Eur J Vasc Endovasc Surg; 2010 Dec; 40(6):817-22. PubMed ID: 20869272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of tigecycline and rifampin alone and in combination against Enterococcus faecalis biofilm infection in a rat model of ureteral stent.
    Minardi D; Cirioni O; Ghiselli R; Silvestri C; Mocchegiani F; Gabrielli E; d'Anzeo G; Conti A; Orlando F; Rimini M; Brescini L; Guerrieri M; Giacometti A; Muzzonigro G
    J Surg Res; 2012 Jul; 176(1):1-6. PubMed ID: 21704328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection.
    Giacometti A; Cirioni O; Ghiselli R; Goffi L; Mocchegiani F; Riva A; Scalise G; Saba V
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3306-9. PubMed ID: 11083632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of tigecycline in combination with gentamicin against biofilm-forming Staphylococcus aureus.
    McConeghy KW; LaPlante KL
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):1-6. PubMed ID: 20727462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
    Atahan E; Gul M; Ergun Y; Eroglu E
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of tigecycline and vancomycin activities in an in vitro biofilm model generated with methicillin-resistant Staphylococcus aureus].
    Aslan H; Yapar N
    Mikrobiyol Bul; 2015 Oct; 49(4):475-83. PubMed ID: 26649405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of quinupristin-dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides.
    Giacometti A; Cirioni O; Ghiselli R; Orlando F; Mocchegiani F; Riva A; Del Prete MS; Saba V; Scalise G
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2885-8. PubMed ID: 12183242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus.
    Giacometti A; Cirioni O; Gov Y; Ghiselli R; Del Prete MS; Mocchegiani F; Saba V; Orlando F; Scalise G; Balaban N; Dell'Acqua G
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1979-83. PubMed ID: 12760879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A
    J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection.
    Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Orlando F; Mocchegiani F; Silvestri C; Licci A; Chiodi L; Lukasiak J; Saba V; Scalise G
    Peptides; 2006 Jun; 27(6):1210-6. PubMed ID: 16289474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP.
    Balaban N; Cirioni O; Giacometti A; Ghiselli R; Braunstein JB; Silvestri C; Mocchegiani F; Saba V; Scalise G
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2226-9. PubMed ID: 17371825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic and local antibiotic prophylaxis in the prevention of Staphylococcus epidermidis graft infection.
    Turgut H; Sacar S; Kaleli I; Sacar M; Goksin I; Toprak S; Asan A; Cevahir N; Tekin K; Baltalarli A
    BMC Infect Dis; 2005 Oct; 5():91. PubMed ID: 16242027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis.
    Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Mocchegiani F; Orlando F; D'Amato G; Rocchi M; Scalise G; Saba V
    Eur J Vasc Endovasc Surg; 2004 Jun; 27(6):603-7. PubMed ID: 15121110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.